Ping An Biomedical will hold its annual general meeting in Hong Kong on March 18, 2026. Shareholders will vote on a proposal to increase authorized share capital from USD 50,000 to USD 312,500 and reclassify ordinary shares into Class A shares. They will also vote to create 100 million Class B shares carrying 100 votes per share and to adopt a second amended and restated memorandum and articles of association. Another resolution seeks approval for the board to repurchase 12.25 million Class A shares from InspireTech in connection with issuing 12.25 million Class B shares to InspireTech. Shareholders will also vote on a share consolidation of Class A and Class B shares at up to a 1-for-1,000 ratio, and related amendments to the company’s governing documents to reflect the consolidation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-025046), on March 09, 2026, and is solely responsible for the information contained therein.